ANALYTICAL AND CLINICAL EVALUATION OF A TAQMAN REAL-TIME PCR ASSAY FOR THE DETECTION OF CHIKUNGUNYA VIRUS



CD36 inhibition enhances the anti-proliferative effects of PI3K inhibitors in PTEN-loss anti-HER2 resistant breast cancer cells

Abstract Background HER2-positive patients comprise approximately 20% of breast cancer cases, with HER2-targeted therapy significantly improving progression-free and overall survival.However, subsequent reprogramed tumor progression due to PI3K signaling pathway activation by PIK3CA mutations and/or PTEN-loss cause anti-HER2 resistance.Previously,

read more